New oral heart failure drug appears to be safe and well tolerated in 58-patient early clinical trial

Article excerpt

An early clinical study shows that a new oral drug is safe and well tolerated in patients with chronic heart failure. The study, led by researchers at Karolinska Institutet, has been published in The Lancet.